A spotlight on BSH 2025: Top abstracts with expert perspective
Published:
As chair of this year’s BSH Top Abstracts session on myeloma and amyloidosis, I wanted to share a few reflections on the standout studies being presented. From updated trial data to potential new treatments, these abstracts offer real insight into where we’re heading and what might be coming next for NHS practice.
Sign up and become a member of the Myeloma UK HCP Hub
Access exclusive content like this and join in the conversation.
Already have an account?